相关实验视频
Updated: Mar 12, 2026

07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
23.4K
将CRISPR/Cas技术与临床试验相结合:原则,进展和挑战
Piao Yang1, Mohadeseh Khoshandam2,3, Iman Bhia4
1Department of Molecular Genetics, College of Arts and Sciences, The Ohio State University, Columbus OH 43210, USA.
Asian journal of pharmaceutical sciences
|March 11, 2026
概括
基因编辑CRISPR为治疗遗传疾病,神经疾病和癌症提供了革命性的潜力. 本次审查强调了基于CRISPR的治疗方法的创新治疗设计和效率改进,解决了临床应用中的未来挑战.
科学领域:
- 生物技术是生物技术.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 基因编辑技术CRISPR已经彻底改变了基因修饰.
- 它的应用在治疗遗传疾病,神经疾病,传染病和癌症方面具有显著的前景.
研究的目的:
- 审查目前使用CRISPR/Cas系统对各种疾病的临床试验.
- 强调针对CRISPR应用的创新准策略和治疗设计.
- 探索CRISPR编辑效率的进步,挑战和管理遗传疾病和癌症的未来潜力.
主要方法:
- 对涉及CRISPR/Cas技术的当前临床试验进行系统审查.
- 对最近的研究进行分析,重点关注CRISPR编辑效率和治疗设计.
- 对基于CRISPR的治疗方法的创新向条件和方法的检查.
主要成果:
- 克里斯普尔技术正在迅速扩展,正在进行的临床试验正在探索其治疗潜力.
- 重点是新的向策略和功能性治疗设计超越传统的交付方法.
- 研究正在积极提高基因疾病和癌症管理的CRISPR编辑效率.
结论:
- 基于CRISPR的疗法显示出未来医疗治疗的变革潜力.
- 对效率,准和克服挑战的持续研究对于扩大临床应用至关重要.
- 本综述为推进CRISPR技术提供了一个独特的视角,以改善患者的治疗结果.
相关概念视频
CRISPR
58.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.6K
CRISPR
18.7K
18.7K
CRISPR/Cas9 Genome Editing
2.3K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.3K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K

